SJS Investment Consulting’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$499 Buy
173
+85
+97% +$216 ﹤0.01% 2272
2026
Q1
$173 Buy
88
+75
+577% +$176 ﹤0.01% 2013
2025
Q4
$36 Buy
+13
New +$43 ﹤0.01% 2042
2024
Q4
Sell
-5
Closed -$35 1644
2024
Q3
$35 Sell
5
-1
-17% -$8 ﹤0.01% 1630
2024
Q2
$47 Hold
6
﹤0.01% 1624
2024
Q1
$43 Sell
6
-1
-14% -$7 ﹤0.01% 1616
2023
Q4
$47 Buy
7
+4
+133% +$23 ﹤0.01% 1591
2023
Q3
$17 Buy
3
+1
+50% +$7 ﹤0.01% 1620
2023
Q2
$12 Hold
2
﹤0.01% 1583
2023
Q1
$13 Buy
+2
New +$11 ﹤0.01% 1573

Other funds holding GDRX

SJS Investment Consulting's GDRX Position: Q2 2026 in Review

SJS Investment Consulting increased its GoodRx Holdings (GDRX) stake by 97% in Q2 2026, buying an estimated $216 and bringing the position to 173 shares worth $499. The position accounts for ﹤0.01% of the portfolio, ranked #2272.

SJS Investment Consulting first reported a position in GDRX in Q1 2023 and has held it in 10 quarters since. 25 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • SJS Investment Consulting held 173 shares of GoodRx Holdings worth $499 as of Q2 2026.
  • SJS Investment Consulting bought 85 GoodRx Holdings shares in Q2 2026, an estimated $216.
  • GoodRx Holdings made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2272 holding.
  • SJS Investment Consulting first reported a position in GoodRx Holdings in Q1 2023 and has held it in 10 quarters since.
  • 25 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.